SalubrisBio is a clinical-stage biotechnology company discovering and developing antibody and protein-based therapeutics. It develops biologic therapeutics that provide clinical improvements in disease. The company focuses on three clinical areas: cardiovascular disease, oncology, and neurodegenerative disease.